BlogHeader.png

Investment of $10.7M in New Facility at Cortex Innovation Center in St. Louis, MO

Wilmington, NC – February 17, 2016 – Alcami, a leading provider of custom manufacturing and development services for the pharmaceutical and biotechnology industries, announced today the planned investment of at least $10.7 Million to relocate its St. Louis, MO analytical testing facility to the Cortex Innovation Center.

Topics: Company News

Expanding Capabilities and Capacity for Sterile Drug Product Manufacturing in Charleston, SC

Wilmington, NC –February 4, 2016 – AAIPharma Services Corp./Cambridge Major Laboratories, Inc. (AAI/CML), a leading provider of custom manufacturing and development services for the pharmaceutical and biotechnology industries, today announces expanded sterile fill-finish capabilities and capacity in its Charleston, SC site. Substantial growth in demand has driven several recent investments.

Topics: Company News

ProForm Select™ Integrated Offering for Solid State Chemistry and Formulation Development

Wilmington, NC –February 4, 2016 – Alcami, a leading provider of custom manufacturing and development services for the pharmaceutical and biotechnology industries announces ProForm Select™, an integrated service offering for solid state chemistry and formulation development to help the pharma/biotech industry meet important milestones and maintain stability in drug development. ProForm Select™ aligns our solid-state, process chemistry and formulation development centers of excellence in Weert, Netherlands, Germantown, Wisconsin and Wilmington, North Carolina. This service is ideal for customers with preclinical small molecules in development. These groups are focused on designing efficient, robust and scalable processes to progress Active Pharmaceutical Ingredients (APIs) from early development to final dosage form. 

Topics: Company News